Do Not Interrupt Gleevec
Posted by Julie Royster (juliecontent) on May 13 2007
GIST In the News >>

A French trial investigating the results of interrupting Gleevec in metastatic GIST patients has been published (click for abstract).  You can read a news story from the National Cancer Institute.   Results indicate imatinib treatment should not be interrupted to avoid reactivation of metastases.

Last changed: May 13 2007 at 1:03 PM

Back